| | | | | | | | | | |
|
|
| Dockets Entered
On August 9, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1977N-0231
|
| PENICILLIN IN ANIMAL FEEDS
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
| 2001C-0486
|
| Tomato lycopene extract to color foods generally
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
| 2005D-0155
|
| Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
|
|
|
| 2005D-0202
|
| Guidance for Industry on Bar Code Label Requirements; Questions and Answers
|
|
|
| 2005D-0203
|
| Guidance for Industry on Safety Testing of Drug Metabolites
|
|
|
| 2005N-0279
|
| Food Labeling; Gluten-Free Labeling of Foods; Public Meeting
|
|
|
| 2005P-0315
|
| ANDA for Ursodiol Oral Suspension, 20 mg/mL
|
|
|
| 2005V-0313
|
| Laser Light Show
|
|
|
| 2005V-0314
|
| Laser Light Show
|
|
|
| 2005V-0316
|
| Laser Light Show
|
|
|
| 1977N-0231
|
| PENICILLIN IN ANIMAL FEEDS
|
|
|
| ANS 624
|
| HFL-1 to Hon. Lee H. Hamilton
|
| Vol #:
|
| 27
|
|
|
| 1998P-0203
|
| Eliminate Forced Molting of Laying Birds
|
|
|
| EMC 3
|
| T. Goodrich
|
| Vol #:
|
| 47
|
|
|
| 2001C-0486
|
| Tomato lycopene extract to color foods generally
|
|
|
| EMC 1
|
| D. Salmon
|
| Vol #:
|
| 1
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| EMC 14486
|
| R. Justin
|
| Vol #:
|
| 342
|
|
|
| EMC 14487
|
| J. Allen
|
| Vol #:
|
| 342
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| EMC 1276
|
| B. Couser
|
| Vol #:
|
| 6
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC
499
|
| Calorie Control Council
|
| Vol #:
|
| 8
|
|
|
| EMC
500
|
| Calorie Control Council
|
| Vol #:
|
| 8
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
| | | | | | | | |
|
|
| EMC 896
|
| C. Rebert
|
| Vol #:
|
| 11
|
|
|
| EMC 897
|
| A. Bibo
|
| Vol #:
|
| 11
|
|
|
| EMC 898
|
| A. Heimerl
|
| Vol #:
|
| 11
|
|
|
| EMC 899
|
| E. Burton
|
| Vol #:
|
| 11
|
|
|
| EMC 900
|
| C. Quinn
|
| Vol #:
|
| 11
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| MO 10
|
| Ecumed Health Group and Amador Reyes, Juan C. Carrai, Richard W. Stone M.D., & Erlinda B. Enri
|
| Vol #:
|
| 2
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
| C
13
|
| Pharmaceutical research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
| C
14
|
| Pfizer, Inc.
|
| Vol #:
|
| 1
|
|
|
| EC
7
|
| Academy of Managed Care Pharmacy
|
| Vol #:
|
| 1
|
|
|
| EC
8
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
9
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
10
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
11
|
| National Consumers League
|
| Vol #:
|
| 1
|
|
|
| EC
12
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
13
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
14
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
15
|
| Pfizer Inc
|
| Vol #:
|
| 1
|
|
|
| EC
16
|
| American Pharmacists Association
|
| Vol #:
|
| 1
|
|
|
| EC
17
|
| Johnson & Johnson
|
| Vol #:
|
| 1
|
|
|
| EC
18
|
| Consumer Healthcare Products Association
|
| Vol #:
|
| 1
|
|
|
| EC
19
|
| American College of Obstetricians & Gynecologists
|
| Vol #:
|
| 1
|
|
|
| EC
20
|
| Pharm Res & Mfrs of America
|
| Vol #:
|
| 1
|
|
|
| EC
21
|
| American Society of Health-System Pharmacists
|
| Vol #:
|
| 1
|
|
|
| 2005D-0155
|
| Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials
|
|
|
| EMC
1
|
| Merck & Co., Inc.
|
| Vol #:
|
| 1
|
|
|
| 2005D-0202
|
| Guidance for Industry on Bar Code Label Requirements; Questions and Answers
|
|
|
| C
4
|
| Wyeth Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
| 2005D-0203
|
| Guidance for Industry on Safety Testing of Drug Metabolites
|
|
| EMC
3
|
| Japan Pharmaceutical Manufacturers Association (JPMA)
|
| Vol #:
|
| 1
|
|
|
| EMC
4
|
| Merck & Co., Inc.
|
| Vol #:
|
| 1
|
|
|
| 2005N-0279
|
| Food Labeling; Gluten-Free Labeling of Foods; Public Meeting
|
|